NASDAQ: CLOV
Clover Health Investments Corp Stock

$3.31-0.09 (-2.65%)
Updated May 14, 2025
CLOV Price
$3.31
Fair Value Price
N/A
Market Cap
$1.68B
52 Week Low
$0.86
52 Week High
$4.87
P/E
-66.2x
P/B
5.01x
P/S
1.2x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.49B
Earnings
-$25.11M
Gross Margin
26.4%
Operating Margin
-1.69%
Profit Margin
-1.7%
Debt to Equity
0.74
Operating Cash Flow
-$7M
Beta
1.45
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CLOV Overview

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CLOV's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Healthcare Plan

Industry Rating
A
CLOV
Ranked
#10 of 10

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$303.35A
$60.04B
$374.29B
View Top Healthcare Plan Stocks

Be the first to know about important CLOV news, forecast changes, insider trades & much more!

CLOV News

Overview

Due Diligence Score

Industry Average (40)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CLOV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CLOV is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CLOV is poor value based on its book value relative to its share price (5.01x), compared to the US Healthcare Plans industry average (1.98x)
P/B vs Industry Valuation
CLOV is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CLOV due diligence checks available for Premium users.

Valuation

CLOV fair value

Fair Value of CLOV stock based on Discounted Cash Flow (DCF)

Price
$3.31
Fair Value
-$3.37
Undervalued by
198.12%
CLOV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CLOV price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-66.2x
Industry
13.49x
Market
26.06x

CLOV price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
5.01x
Industry
1.98x
CLOV is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CLOV's financial health

Profit margin

Revenue
$462.3M
Net Income
-$1.3M
Profit Margin
-0.3%
CLOV's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
CLOV's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$583.7M
Liabilities
$247.6M
Debt to equity
0.74
CLOV's short-term assets ($331.41M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CLOV's short-term assets ($331.41M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CLOV's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CLOV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$16.3M
Investing
$8.9M
Financing
-$31.7M
CLOV's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CLOV vs Healthcare Plan Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CLOVC$1.68B-2.65%-66.20x5.01x
ALHCC$2.95B+6.12%-31.06x27.28x
NEUE$61.07M-0.15%-0.31x-0.04x
OSCRC$4.21B-2.25%34.46x3.16x
MOHC$16.89B+0.38%14.99x3.92x

Clover Health Investments Stock FAQ

What is Clover Health Investments's quote symbol?

(NASDAQ: CLOV) Clover Health Investments trades on the NASDAQ under the ticker symbol CLOV. Clover Health Investments stock quotes can also be displayed as NASDAQ: CLOV.

If you're new to stock investing, here's how to buy Clover Health Investments stock.

What is the 52 week high and low for Clover Health Investments (NASDAQ: CLOV)?

(NASDAQ: CLOV) Clover Health Investments's 52-week high was $4.87, and its 52-week low was $0.86. It is currently -32.03% from its 52-week high and 283.1% from its 52-week low.

How much is Clover Health Investments stock worth today?

(NASDAQ: CLOV) Clover Health Investments currently has 508,916,581 outstanding shares. With Clover Health Investments stock trading at $3.31 per share, the total value of Clover Health Investments stock (market capitalization) is $1.68B.

Clover Health Investments stock was originally listed at a price of $10.07 in Apr 22, 2020. If you had invested in Clover Health Investments stock at $10.07, your return over the last 5 years would have been -67.13%, for an annualized return of -19.95% (not including any dividends or dividend reinvestments).

How much is Clover Health Investments's stock price per share?

(NASDAQ: CLOV) Clover Health Investments stock price per share is $3.31 today (as of May 14, 2025).

What is Clover Health Investments's Market Cap?

(NASDAQ: CLOV) Clover Health Investments's market cap is $1.68B, as of May 15, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Clover Health Investments's market cap is calculated by multiplying CLOV's current stock price of $3.31 by CLOV's total outstanding shares of 508,916,581.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.